Breadcrumb

Breadcrumbs

Estás en:

Asset Publisher

INFORME INAHTA

Informe completoTranscatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk

Resumen: Transcatheter aortic valve implantation

Objetivo: Health Technology Wales undertook an evidence review to address the following question: Is transcatheter aortic valve implantation (TAVI) clinically and cost effective for severe symptomatic aortic stenosis in adults who are assessed by a heart team as being operable but at intermediate surgical risk? This review is an adaptation and update of the Scottish Health Technologies Group (SHTG) Evidence note 91: Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis at intermediate surgical risk (SHTG 2019).

Autoría: Health Technology Wales

Idioma: inglés

Fuente: INAHTA

Año de publicación: 2020